mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |